JP2016506913A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506913A5 JP2016506913A5 JP2015553119A JP2015553119A JP2016506913A5 JP 2016506913 A5 JP2016506913 A5 JP 2016506913A5 JP 2015553119 A JP2015553119 A JP 2015553119A JP 2015553119 A JP2015553119 A JP 2015553119A JP 2016506913 A5 JP2016506913 A5 JP 2016506913A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- cancer
- pharmaceutical composition
- composition according
- carboxydimethylmethyloxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 206010016654 Fibrosis Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 230000004761 fibrosis Effects 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- LVOICKNPHXSSQM-UHFFFAOYSA-N prop-2-en-1-one Chemical compound C=C[C]=O LVOICKNPHXSSQM-UHFFFAOYSA-N 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 210000002744 Extracellular Matrix Anatomy 0.000 claims 2
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 2
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 2
- 210000004027 cells Anatomy 0.000 claims 2
- 229960005188 collagen Drugs 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 230000003176 fibrotic Effects 0.000 claims 2
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 101700015297 lov Proteins 0.000 claims 2
- 206010059512 Apoptosis Diseases 0.000 claims 1
- 210000001185 Bone Marrow Anatomy 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 206010009887 Colitis Diseases 0.000 claims 1
- 206010011401 Crohn's disease Diseases 0.000 claims 1
- 208000008334 Dermatofibrosarcoma Diseases 0.000 claims 1
- 206010057070 Dermatofibrosarcoma protuberans Diseases 0.000 claims 1
- 206010017758 Gastric cancer Diseases 0.000 claims 1
- 210000002216 Heart Anatomy 0.000 claims 1
- 206010073071 Hepatocellular carcinoma Diseases 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- 102100013180 KDR Human genes 0.000 claims 1
- 208000002260 Keloid Diseases 0.000 claims 1
- 210000001117 Keloid Anatomy 0.000 claims 1
- 206010023330 Keloid scar Diseases 0.000 claims 1
- 206010024324 Leukaemias Diseases 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000008585 Mastocytosis Diseases 0.000 claims 1
- 208000002805 Mediastinal Fibrosis Diseases 0.000 claims 1
- 206010027191 Meningioma Diseases 0.000 claims 1
- 210000003205 Muscles Anatomy 0.000 claims 1
- 206010028537 Myelofibrosis Diseases 0.000 claims 1
- 208000010125 Myocardial Infarction Diseases 0.000 claims 1
- 206010028594 Myocardial fibrosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000009905 Neurofibromatosis Diseases 0.000 claims 1
- 102100004939 PDGFRB Human genes 0.000 claims 1
- 101710018346 PDGFRB Proteins 0.000 claims 1
- 206010067517 Pancreatic neuroendocrine tumour Diseases 0.000 claims 1
- 206010034464 Periarthritis Diseases 0.000 claims 1
- 208000003476 Primary Myelofibrosis Diseases 0.000 claims 1
- 206010036805 Progressive massive fibrosis Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000005069 Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000006265 Renal Cell Carcinoma Diseases 0.000 claims 1
- 206010038979 Retroperitoneal fibrosis Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 108091007928 VEGF receptors Proteins 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 230000001070 adhesive Effects 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 201000011231 colorectal cancer Diseases 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 201000009794 idiopathic pulmonary fibrosis Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 230000002071 myeloproliferative Effects 0.000 claims 1
- 201000004931 neurofibromatosis Diseases 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 230000000268 renotropic Effects 0.000 claims 1
- 210000004872 soft tissue Anatomy 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000009594 systemic scleroderma Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 201000002527 tumor of exocrine pancreas Diseases 0.000 claims 1
Claims (9)
- 肝線維症ではない線維性疾患を治療若しくは予防するため、又はチロシンキナーゼ関連ガンを治療若しくは予防するための方法に使用するための、化合物1−[4−メチルチオフェニル]−3−[3,5−ジメチル−4−カルボキシジメチルメチルオキシフェニル]プロパ−2−エン−1−オンを含む医薬組成物。
- 線維性疾患が、肺、心臓、筋肉、皮膚、軟組織、骨髄、腸及び関節の線維症である、請求項1に記載の医薬組成物。
- 線維性疾患が、肺線維症、特発性肺線維症、嚢胞性線維症、心内膜心筋線維症、縦隔線維症、骨髄線維症、後腹膜線維症、進行性塊状線維症、腎性全身性線維症、炎症性腸疾患(IBD)関連繊維症、大腸炎関連繊維症、クローン病、ケロイド、陳旧性心筋梗塞、強皮症/全身性硬化症、関節線維症又は癒着性関節包炎である、請求項1に記載の医薬組成物。
- チロシンキナーゼ関連ガンが、PDGFR関連ガン、VEGFR関連ガン又はKIT関連ガンである、請求項1に記載の医薬組成物。
- ガンが、腎細胞ガン腫;消化管間質腫瘍(GIST);胃ガン;神経線維腫症を伴う髄膜腫;膵臓神経内分泌腫瘍;膵臓外分泌腫瘍;白血病;骨髄増殖性疾患/骨髄異形成疾患;肥満細胞症;皮膚線維肉腫;乳ガン、肺ガン、甲状腺ガン若しくは結腸直腸ガン又は前立腺ガンを含む固形腫瘍である、請求項1又は4に記載の医薬組成物。
- 肝臓ガンを根治治療するための方法に使用するための、化合物1−[4−メチルチオフェニル]−3−[3,5−ジメチル−4−カルボキシジメチルメチルオキシフェニル]プロパ−2−エン−1−オンを含む医薬組成物。
- 肝臓ガンが肝細胞ガン腫である、請求項6に記載の医薬組成物。
- コラーゲン線維の産生に関与し、及び/又は細胞外マトリックスの産生に関与する細胞の増殖及び/又は活性化を阻害するのに使用するための、化合物1−[4−メチルチオフェニル]−3−[3,5−ジメチル−4−カルボキシジメチルメチルオキシフェニル]プロパ−2−エン−1−オンを含む医薬組成物。
- コラーゲン線維の産生に関与し、及び/又は細胞外マトリックスの産生に関与する細胞のアポトーシスを促進するのに使用するための、化合物1−[4−メチルチオフェニル]−3−[3,5−ジメチル−4−カルボキシジメチルメチルオキシフェニル]プロパ−2−エン−1−オンを含む医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13305067 | 2013-01-18 | ||
EP13305067.4 | 2013-01-18 | ||
PCT/EP2014/051060 WO2014111584A1 (en) | 2013-01-18 | 2014-01-20 | Methods of treatment of fibrosis and cancers |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016506913A JP2016506913A (ja) | 2016-03-07 |
JP2016506913A5 true JP2016506913A5 (ja) | 2017-01-12 |
JP6218854B2 JP6218854B2 (ja) | 2017-10-25 |
Family
ID=47628079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015553119A Active JP6218854B2 (ja) | 2013-01-18 | 2014-01-20 | 線維症及びガンの治療方法 |
Country Status (26)
Country | Link |
---|---|
US (2) | US20150352065A1 (ja) |
EP (1) | EP2948137B1 (ja) |
JP (1) | JP6218854B2 (ja) |
KR (1) | KR102196277B1 (ja) |
CN (1) | CN105120855B (ja) |
AU (1) | AU2014206781B2 (ja) |
CA (1) | CA2897258C (ja) |
CY (1) | CY1121156T1 (ja) |
DK (1) | DK2948137T3 (ja) |
EA (1) | EA031718B1 (ja) |
ES (1) | ES2702038T3 (ja) |
HK (1) | HK1214773A1 (ja) |
HU (1) | HUE042569T2 (ja) |
IL (1) | IL239715B (ja) |
LT (1) | LT2948137T (ja) |
MD (1) | MD4629B1 (ja) |
MX (1) | MX361565B (ja) |
NZ (1) | NZ709420A (ja) |
PH (1) | PH12015501566A1 (ja) |
PL (1) | PL2948137T3 (ja) |
PT (1) | PT2948137T (ja) |
SG (1) | SG11201505281PA (ja) |
SI (1) | SI2948137T1 (ja) |
TR (1) | TR201819042T4 (ja) |
WO (1) | WO2014111584A1 (ja) |
ZA (1) | ZA201505151B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2948137T (pt) | 2013-01-18 | 2018-12-20 | Genfit | Métodos de tratamento de fibrose e de cancro |
JP2019505598A (ja) * | 2016-02-23 | 2019-02-28 | セルジーン アルパイン インベストメント カンパニー Ii, エルエルシー | Smad7の阻害を用いて、腸線維症を治療する方法 |
WO2018193007A1 (en) | 2017-04-18 | 2018-10-25 | Genfit | Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor |
US20210309608A1 (en) | 2018-08-03 | 2021-10-07 | Genfit | Elafibranor salts |
GB201901507D0 (en) * | 2019-02-04 | 2019-03-27 | St Georges Hospital Medical School | New treatment |
JP2023513712A (ja) | 2020-02-10 | 2023-04-03 | ジェンフィット | エラフィブラノールの多形体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7736677B2 (en) * | 2001-06-20 | 2010-06-15 | Metaproteomics, Llc | Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
FR2841784B1 (fr) * | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
FR2857361B1 (fr) * | 2003-07-08 | 2005-09-09 | Genfit S A | PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one |
PL2504005T3 (pl) | 2009-11-26 | 2014-03-31 | Genfit | Zastosowanie pochodnych 1,3-difenyloprop-2-en-1-onu do leczenia zaburzeń wątroby |
ES2384060B1 (es) * | 2010-03-24 | 2013-09-23 | Lipotec S.A. | Cápsulas de nanopartículas lipídicas. |
PT2948137T (pt) | 2013-01-18 | 2018-12-20 | Genfit | Métodos de tratamento de fibrose e de cancro |
-
2014
- 2014-01-20 PT PT14702771T patent/PT2948137T/pt unknown
- 2014-01-20 NZ NZ709420A patent/NZ709420A/en unknown
- 2014-01-20 WO PCT/EP2014/051060 patent/WO2014111584A1/en active Application Filing
- 2014-01-20 MX MX2015009251A patent/MX361565B/es active IP Right Grant
- 2014-01-20 AU AU2014206781A patent/AU2014206781B2/en active Active
- 2014-01-20 TR TR2018/19042T patent/TR201819042T4/tr unknown
- 2014-01-20 DK DK14702771.8T patent/DK2948137T3/en active
- 2014-01-20 PL PL14702771T patent/PL2948137T3/pl unknown
- 2014-01-20 KR KR1020157021736A patent/KR102196277B1/ko active IP Right Grant
- 2014-01-20 SI SI201431009T patent/SI2948137T1/sl unknown
- 2014-01-20 HU HUE14702771A patent/HUE042569T2/hu unknown
- 2014-01-20 US US14/760,880 patent/US20150352065A1/en not_active Abandoned
- 2014-01-20 CN CN201480005335.0A patent/CN105120855B/zh active Active
- 2014-01-20 EP EP14702771.8A patent/EP2948137B1/en active Active
- 2014-01-20 JP JP2015553119A patent/JP6218854B2/ja active Active
- 2014-01-20 LT LTEP14702771.8T patent/LT2948137T/lt unknown
- 2014-01-20 CA CA2897258A patent/CA2897258C/en active Active
- 2014-01-20 MD MDA20150076A patent/MD4629B1/ro not_active IP Right Cessation
- 2014-01-20 SG SG11201505281PA patent/SG11201505281PA/en unknown
- 2014-01-20 ES ES14702771T patent/ES2702038T3/es active Active
- 2014-01-20 EA EA201591345A patent/EA031718B1/ru not_active IP Right Cessation
-
2015
- 2015-06-30 IL IL239715A patent/IL239715B/en active IP Right Grant
- 2015-07-14 PH PH12015501566A patent/PH12015501566A1/en unknown
- 2015-07-17 ZA ZA2015/05151A patent/ZA201505151B/en unknown
-
2016
- 2016-03-11 HK HK16102854.3A patent/HK1214773A1/zh unknown
-
2017
- 2017-05-04 US US15/586,456 patent/US10792277B2/en active Active
-
2018
- 2018-12-14 CY CY20181101346T patent/CY1121156T1/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016506913A5 (ja) | ||
CL2011001060A1 (es) | Compuestos derivados de 4-[3-{3-(1,2,4-oxadiazol-5-il)-1h-pirazol-1-il}-metil]-piridina, 3-[3-{3-(1,2,4-oxadiazol-5-il)-1h-pirazol-1-il}-metil)-fenilo, 3-[3-{3-(1,2,4-oxadiazol-5-il)-1h-pirazol-1-il}-metil)-fenilo; procedimiento de preparacion; composicion farmaceutica; utiles para tratar enfermedades cancerosas o tumorales. | |
PH12017500635A1 (en) | Aminopyridyloxypyrazole compounds | |
MX2015000830A (es) | Derivados heterociclicos nitrogenosos y su aplicacion en farmacos. | |
JP2017516775A5 (ja) | ||
CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
MY160445A (en) | Dual Variable Domain Immunoglobulins And Uses Thereof | |
WO2016004389A3 (en) | Monovalent binding proteins | |
NZ739339A (en) | Apoptosis signal-regulating kinase inhibitor | |
SG10201803833WA (en) | Heterocyclic compounds useful in the treatment of disease | |
WO2009103741A3 (en) | Use of fsh receptor ligands for diagnosis and therapy of cancer | |
SG10201906400SA (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
JP2015502926A5 (ja) | ||
WO2015171558A3 (en) | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE | |
WO2016057658A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
PH12015501566A1 (en) | Methods of treatment of fibrosis and cancers | |
WO2015074010A8 (en) | Compositions and methods for cardiac regeneration | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
JP2019511525A5 (ja) | ||
FI3870233T3 (fi) | Paklitakseli-Hyaluronihapon konjugaatti käytettäväksi ei-lihasinvasiivisen virtsarakon syövän hoidossa | |
JP2020514345A5 (ja) | ||
EP3565636C0 (en) | USE OF THE GUT MICROBIOTA IN THE DIAGNOSIS OF PARKINSON’S DISEASE | |
Aras et al. | Breast cancer lung metastases incidentally detected on bone SPECT/CT: a rare finding that might be missed on whole body scan | |
MX2021002516A (es) | Modificaciones de solvente a sustratos prehumedecidos. | |
Польщакова et al. | Efficiency of balneoradonotherapy by mineral water from well№ 604 of Ostrivnoy area Khmelnytsky deposit Vinnytsa region in the sanatorium" Radon"(Khmilnyk) |